Haemonetics (HAE) Change in Receivables (2009 - 2026)

Haemonetics' Change in Receivables history runs 18 years deep, the most recent figure standing at $22.2 million for Q1 2026.

• On a quarterly basis, Change in Receivables rose 315.16% year-over-year to $22.2 million in Q1 2026; TTM through Mar 2026 was $14.9 million, a 313.93% increase from a year earlier, with the FY2026 full-year figure at $14.9 million, up 313.93% from the prior year.
• Change in Receivables improved to $22.2 million in Q1 2026 per HAE's latest filing, from -$11.1 million in the prior quarter.
• Across five years, Change in Receivables topped out at $30.6 million in Q4 2023 and bottomed at -$11.1 million in Q4 2025.
• The 5-year median for Change in Receivables is $911000.0 (2023), against an average of $4.3 million.
• Biggest YoY gain for Change in Receivables was 618.57% in 2024; the steepest drop was 7060.78% in 2024.
• Year by year, Change in Receivables stood at $7.3 million in 2022, then surged by 317.63% to $30.6 million in 2023, then sank by 94.21% to $1.8 million in 2024, then plunged by 724.39% to -$11.1 million in 2025, then soared by 301.09% to $22.2 million in 2026.
• Per Business Quant, the three latest HAE Change in Receivables figures stand at $22.2 million (Q1 2026), -$11.1 million (Q4 2025), and $7.3 million (Q3 2025).